Renovaro Biosciences Inc Net Asset Quality Index
Renovaro Biosciences Inc net asset quality index. Renovaro Biosciences Inc (RENB) has a Net Asset Quality Index of -259.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.23 Million minus total liabilities of $29.58 Million yields net assets of $-21.35 Million. A higher index indicates a stronger, lower-leverage balance sheet. See RENB net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Renovaro Biosciences Inc (2012–2025)
Net asset quality index of Renovaro Biosciences Inc from 2012 to 2025. This chart shows how Renovaro Biosciences Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2025, the index stands at -259.4%, representing net assets of $-21.35 Million against total assets of $8.23 Million USD. Check Renovaro Biosciences Inc (RENB) strategic investment index to assess the company's strategic physical and investment asset allocation.
Renovaro Biosciences Inc Net Asset Quality Index by Year (2012–2025)
Renovaro Biosciences Inc net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Renovaro Biosciences Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Renovaro Biosciences Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.9% | $131.98 Million | $163.13 Million | $31.15 Million | ▲ +0.0 pp |
| 2024 | 80.9% | $131.98 Million | $163.13 Million | $31.15 Million | ▲ +1.1 pp |
| 2023 | 79.8% | $46.50 Million | $58.30 Million | $11.80 Million | ▼ -6.0 pp |
| 2022 | 85.8% | $72.62 Million | $84.63 Million | $12.01 Million | ▼ -6.3 pp |
| 2021 | 92.1% | $174.66 Million | $189.61 Million | $14.94 Million | ▼ -1.2 pp |
| 2020 | 93.4% | $166.27 Million | $178.10 Million | $11.83 Million | ▼ -2.9 pp |
| 2019 | 96.2% | $173.10 Million | $179.88 Million | $6.78 Million | ▲ +9.3 pp |
| 2018 | 87.0% | $158.74 Million | $182.50 Million | $23.76 Million | ▲ +53.1 pp |
| 2017 | 33.9% | $1.53 Million | $4.52 Million | $2.99 Million | ▲ +107.1 pp |
| 2016 | -73.2% | $-637.40K | $870.83K | $1.51 Million | ▼ -139.7 pp |
| 2015 | 66.5% | $3.48 Million | $5.24 Million | $1.76 Million | ▲ +386.5 pp |
| 2014 | -320.0% | $-1.60 Million | $500.00K | $2.10 Million | ▼ -63.2 pp |
| 2013 | -256.8% | $-51.27K | $19.96K | $71.23K | ▼ -155.9 pp |
| 2012 | -100.9% | $-13.68K | $13.55K | $27.23K | — |